A group of researchers presented an innovative method of diagnostics that determines the probability of death of the person against future infections. The risk can be predicted for the next 14 years.
The program takes into account most of the common viral and bacterial infections that can kill a person. The method was tested on 10 thousand volunteers. Identified biological marker of GlycA produced in the human body in response to inflammation. Scientists believe that a high level of marker can speak and pathological immune response to infection.
While the test system is at the laboratory stage of development. Scientists can't create the next stage of diagnosis, which was allocated a false reaction of the immune system with higher levels of GlycA.